![Amos Eiran](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Amos Eiran
Chairman at Atudot-Executive Search Ltd.
Network origin in Amos Eiran first degree
Entity | Entity type | Industry | |
---|---|---|---|
Celsus Therapeutics Plc
![]() Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Celsus Therapeutics Plc is a drug development company, which focuses on developing novel, first-in-class, non-steroidal, synthetic anti-inflammatory drugs and multi-functional anti-inflammatory drugs. The company main clinical candidates are MRX-5, MRX-6, MRX-4, CFX-1 and OPX-1. Celsus Therapeutics was founded on October 7, 2004 and is headquartered in London, the United Kingdom.
8
| Extinct | Pharmaceuticals: Major | 8 |
Medis El Ltd.
![]() Medis El Ltd. Medical SpecialtiesHealth Technology Part of Medis Technologies Ltd., Medis El Ltd. is a manufacturer of direct liquid fuel cell products for portable electronic devices. The company is based in Lod, Israel. Medis El was acquired by Medis Technologies Ltd. on June 05, 2000.
4
| Subsidiary | Medical Specialties | 4 |
Atudot-Executive Search Ltd.
![]() Atudot-Executive Search Ltd. Personnel ServicesCommercial Services Atudot-Executive Search Ltd. provides recruitment solutions. The company was founded in 1986 and is headquartered in Tel Aviv, Israel.
1
| Private Company | Personnel Services | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Amos Eiran via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Medis Technologies Ltd.
![]() Medis Technologies Ltd. Medical SpecialtiesHealth Technology Medis Technologies Ltd. develops, manufactures, markets and distributes direct liquid fuel cell products for portable electronic devices. The company was founded in 1992 and is headquartered in New York, NY. | Medical Specialties | Director/Board Member Director/Board Member Director of Finance/CFO General Counsel | |
AKARI THERAPEUTICS, PLC | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer | |
More Energy Ltd.
![]() More Energy Ltd. Medical SpecialtiesHealth Technology Part of Medis Technologies Ltd., More Energy Ltd. is an Israeli company that manufactures direct liquid fuel cell products for portable electronic devices. The company is based in Lod, Israel. More Energy was acquired by Medis Technologies Ltd. on March 31, 2003. | Medical Specialties | Director of Finance/CFO General Counsel | |
NAVIOS MARITIME HOLDINGS INC. | Marine Shipping | Director/Board Member | |
Enobia Pharma, Inc.
![]() Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Enobia Pharma, Inc. develops therapies to treat patients with ultra-rare and life-threatening genetic metabolic bone disorders. Its lead product candidate, asfotase alfa or ENB-0040, is a treatment for hypophosphatasia—a life-threatening disease that can cause skeletal deformity, severe muscle weakness and progressive damage to vital organs. The company was founded in 1997 and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Director/Board Member | |
CHIASMA, INC. | Pharmaceuticals: Major | Chairman | |
Pfizer Pharmaceuticals, Inc.
![]() Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer Pharmaceuticals, Inc. is an American company that manufactures pharmaceutical products. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Glycadia, Inc.
![]() Glycadia, Inc. Pharmaceuticals: MajorHealth Technology Glycadia, Inc. is a clinical-stage biopharmaceutical company that develops therapeutics for the prevention and treatment of kidney, eye, cardiovascular, and related diseases resulting from diabetes. The private company is based in Philadelphia, PA, and has subsidiaries in the United States. The company's science is based on recent discoveries concerning the causal role of circulating glycated. Glycadia's experienced R&D team is bringing new scientific discoveries to clinical trials of innovative products for complications of diabetes, including nephropathy, retinopathy, and cardiovascular disease. | Pharmaceuticals: Major | Chairman | |
Dartmouth College | College/University | Undergraduate Degree | |
RxFDP | Founder | ||
REGENERON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Chief Executive Officer | |
Pharmasset, Inc.
![]() Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Pharmaceuticals: Other | Director/Board Member | |
OMRIX Biopharmaceuticals, Inc.
![]() OMRIX Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OMRIX Biopharmaceuticals, Inc. specializes in the manufacture and development of biosurgical and passive immunotherapy products. Its product range encompasses hemostatic, surgical, and immunotherapy solutions. The firm offers solutions for bleeding control, surgical operations, and biodefense applications. The company was founded by Robert Taub in 1995 and is headquartered in Somerville, NJ. | Pharmaceuticals: Major | Chairman | |
Zymenex A/S
![]() Zymenex A/S BiotechnologyHealth Technology Zymenex A/S researches and develops therapeutics for life threatening diseases. The firm commercializes novel enzyme replacement therapies for the treatment of life-threatening, rare genetic diseases. The company was founded by Jens Fogh and Pär Gellerfors in 1998 and is headquartered in Hillerod, Denmark. | Biotechnology | Chairman | |
SomPharmaceuticals GmbH
![]() SomPharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology SomPharmaceuticals SA develops anti-tumor somatostatin analogue peptide medicines and diagnostics for patients with neuroendocrine diseases. The company was founded by Alan G. Harris in 2012 and is headquartered in Zug, Switzerland. | Pharmaceuticals: Major | Founder | |
RADIUS HEALTH, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Pfizer Ltd.
![]() Pfizer Ltd. Pharmaceuticals: MajorHealth Technology Pfizer Ltd. is a biopharmaceutical company that develops and provides medicines, vaccines, and consumer healthcare products. Its products include prescription and counterfeit medicines, and over-the-counter products. The company was founded in 1952 and is headquartered in Tadworth, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Schering-Plough Corp.
![]() Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Novartis Corp.
![]() Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
Cedars-Sinai Medical Center
![]() Cedars-Sinai Medical Center Hospital/Nursing ManagementHealth Services Cedars-Sinai Medical Center operates a hospital that provides healthcare services. It specializes in cancer, endocrinology, gynecology, neurology, orthopedics, and respiratory disorders. The company was founded in 1902 and is headquartered in Los Angeles, CA. | Hospital/Nursing Management | Chief Tech/Sci/R&D Officer | |
University of California, Los Angeles | College/University | Corporate Officer/Principal | |
University of Strasbourg | College/University | Doctorate Degree | |
NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Erasmus University Rotterdam | College/University | Doctorate Degree | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
Bar-Ilan University | College/University | Undergraduate Degree | |
CELL KINETICS LTD. | Biotechnology | Director of Finance/CFO | |
Altrubio, Inc.
![]() Altrubio, Inc. Internet RetailRetail Trade Altrubio, Inc. is a clinical-stage biotechnology company based in Redwood City, CA. The company specializes in developing novel therapies leveraging immune checkpoint agonism to enhance the function of natural pathways to downregulate an overactivated immune system. Altrubio's pipeline includes two clinical stage product candidates: neihulizumab, an immune checkpoint agonist antibody targeting PSGl-1/CD162 that depletes unwanted activated T cells with proof of mechanism in four autoimmune and inflammatory diseases, and ABGN-107, an antibody-drug conjugate employing a unique enzyme cleavable hydrophilic self-immolative linker and targeting a gastrointestinal tumor antigen. The company was founded in 2000, and the CEO is Judy Chou. | Internet Retail | Director/Board Member | |
Ziarco Pharma Ltd.
![]() Ziarco Pharma Ltd. BiotechnologyHealth Technology Ziarco Pharma Ltd. provides therapeutics targeting inflammatory and allergic diseases. It focuses on chronic inflammatory skin diseases, atopic dermatitis, and Psoriasis. The company was founded by Michael Yeadon, Wai Leung Liu, Lynn Worth Purkins and Arif Kassam Shivji in 2012 and is headquartered in Sandwich, the United Kingdom. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Universidad Central Del Ecuador | College/University | Doctorate Degree | |
Corbus Pharmaceuticals, Inc.
![]() Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | Pharmaceuticals: Major | Chief Executive Officer | |
CORBUS PHARMACEUTICALS HOLDINGS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
University of Cape Town | College/University | Undergraduate Degree | |
ZEPHYRUS WING ENERGIES LTD | Alternative Power Generation | General Counsel | |
BRENMILLER ENERGY LTD | Engineering & Construction | General Counsel | |
Israel Bar Association
![]() Israel Bar Association Miscellaneous Commercial ServicesCommercial Services Israel Bar Association is a private company headquartered in Tel Aviv, Israel. The firm provides legal services. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
NICE LTD. | Information Technology Services | General Counsel | |
Biosplice Therapeutics, Inc.
![]() Biosplice Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Biosplice Therapeutics, Inc. provides medical research and development for tissue-level regeneration. It develops therapeutics to address a range of degenerative diseases, regenerative medicine and oncology. The company was founded by Osman Kibar and John Hood in 2008 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
KAHR Medical Ltd.
![]() KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel. | Pharmaceuticals: Major | Director/Board Member | |
aMoon Ventures Y Sh Ltd.
![]() aMoon Ventures Y Sh Ltd. Investment ManagersFinance aMoon Ventures Y Sh Ltd (aMoon Ventures) is an venture capital firm founded in 2016 by Marius Nacht and Dr. Yair Schindel. The firm is headquartered in Israel. | Investment Managers | Private Equity Investor | |
Tel-Aviv University
![]() Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Masters Business Admin | |
VIRACTA THERAPEUTICS, INC. | Biotechnology | Director/Board Member |
Statistics
International
United States | 28 |
Israel | 12 |
United Kingdom | 4 |
France | 3 |
Cayman Islands | 2 |
Sectoral
Health Technology | 28 |
Consumer Services | 11 |
Commercial Services | 5 |
Distribution Services | 2 |
Transportation | 2 |
Operational
Director/Board Member | 59 |
Corporate Officer/Principal | 24 |
Chairman | 17 |
Independent Dir/Board Member | 15 |
Chief Executive Officer | 11 |
Most connected contacts
Insiders | |
---|---|
David Sidransky | 32 |
Allan Shaw | 23 |
Gur Roshwalb | 17 |
Fredric D. Price | 16 |
Alan G. Harris | 14 |
Robert Francis Doman | 7 |
Jasmine Wagman-Negev | 7 |
Zeev Nahmoni | 6 |
Israel Fisher | 6 |
Aimos Eiran | 5 |
Yuval Cohen | 5 |
Pablo Jimenez | 4 |
Baruch Shapira | 1 |
- Stock Market
- Insiders
- Amos Eiran
- Company connections